NEW YORK (The Street) -- Healthcare supplies provider Halyard Health (HYH) became a publicly-traded company at the end of October as a spinoff from Kimberly-Clark (KMB). Shares of Halyard began slipping immediately, falling to as low as $35.56 on Nov. 5, then began to rebound. Once the stock had been traded for 50 sessions the 50-day simple moving average could be tracked. This moving average held as a technical support between Feb. 20 and March 6, and the stock traded as high as $50.91 on April 9.
On May 5 the stock gapped below the 50-day average, and it traded as low as $41.25 this morning.
Exclusive Look Inside:
You see Jim Cramer on TV. Now, see where he invests his money and why Halyard Health is a core holding of his multi-million dollar portfolio. Want to be alerted before Jim Cramer buys or sells HYH? Learn more now.
This volatility prompted Jack Mohr, Director of Research, Action Alerts PLUS, to send us a Tweet: "Fingers crossed but I think we may have found a bottom in Halyard- yesterday. At v least it's not going under $40. Steal @ this price."
Here's an analysis of the daily chart, which suggests that Jack could be correct. Keep in mind that, because it's a newly-public company, historical data for Halyard is limited.
Courtesy of MetaStock Xenith
Tuesday's price action for shares of Halyard Health is a potential key reversal. After setting a low of $41.25 this morning, a close above Monday's high of $42.30 would be a key reversal. By definition, higher closes on Wednesday and Thursday will confirm the reversal and indicate a potential tradeable rebound to the 50-day simple moving average of $47.52.